Tweetovi
- Tweetovi, trenutna stranica.
- Tweetovi i odgovori
- Medijski sadržaj
Blokirali ste korisnika/cu @fdinicolantonio
Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @fdinicolantonio
-
Prikvačeni tweet
Cancer cells modulate DNA repair in response to
#target therapy. This improves their odds of developing a mutation that will confer drug resistance and allow them to survive.https://science.sciencemag.org/content/early/2019/11/06/science.aav4474 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
F. Di Nicolantonio proslijedio/la je Tweet
This is our cells under pressure.. Thanks for this insightful Previews of our work on
@Cancer_Cell https://www.cell.com/cancer-cell/fulltext/S1535-6108(19)30575-6 …@Albert0Bardelli@fdinicolantonio@sciencemagazine@fpoirccs@AIRC_itHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
F. Di Nicolantonio proslijedio/la je Tweet
#EACR2020: We are delighted to offer participants free childcare onsite at EACR 2020, supplied by Nipperbout Event Childcare. Places are limited and must be pre-booked, so register your interest now! To find out more, please visit: https://www.eacr2020.org/childcare pic.twitter.com/skCLKBNJz4
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
F. Di Nicolantonio proslijedio/la je Tweet
Our paper is out today! Crizotinib is the first MET inhibitor to prospectively show activity in METex14-altered NSCLC, is widely available, and is in the NCCN guidelines for this indication. A great treatment option while we wait for the potential approval of a selective MET TKI.https://twitter.com/NatureMedicine/status/1216769113449738240 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
F. Di Nicolantonio proslijedio/la je Tweet
Can we challenge the long held hypothesis that resistance to targeted therapy in cancer is present at the time of therapy start? Can we leverage liquid biopsy to monitor? Fantastic talk by
@Albert0Bardelli@BardelliLabpic.twitter.com/gMlfh9mtSI
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
F. Di Nicolantonio proslijedio/la je Tweet
A machine learning algorithm uses circulating tumor DNA methylation markers for the diagnosis, prognostication, and surveillance of
#colorectal cancerhttps://stm.sciencemag.org/content/12/524/eaax7533.full …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
F. Di Nicolantonio proslijedio/la je Tweet
WE HAVE SOMETHING TO CELEBRATE: OUR FIRST FULL ISSUE @NatureCancer IS LIVE
- GIVE US BIGGER CAPS TO SHOW OUR EXCITEMENT!!
Massive congrats to the team, and thanks to everyone that made this a reality. Stay tuned for our content: https://www.nature.com/natcancer/ pic.twitter.com/rtAg91gbst
Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
F. Di Nicolantonio proslijedio/la je Tweet
The first issue of
@NatureCancer is out today. Proud that our lab has contributed one paper in it https://www.nature.com/articles/s43018-019-0001-2 …pic.twitter.com/VeP3bAPsLv
Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
F. Di Nicolantonio proslijedio/la je Tweet
Holy smokes, this is a cool
@PNASNews paper on intratumoral injection of#FluShot &#ImmunoOnc. Work of Drs. Jenna Newman, Andrew Zloza et al@RutgersU@RushMedical. First few pgs
. Full paper & datasets at link w/ no paywall. #immunotherapy#oncology https://www.pnas.org/content/early/2019/12/26/1904022116 …pic.twitter.com/yN4ZI0MwMR
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
F. Di Nicolantonio proslijedio/la je Tweet
Last year, we invited
@bbc5live to our animal research facility to find out more about the role of mice in cancer research. And this week the broadcast won an@animalresearch openness award!
Listen to the programme
https://www.bbc.co.uk/sounds/play/p06svtks …https://www.crick.ac.uk/news/2019-12-05_the-crick-wins-award-for-open-communication-of-animal-research …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
F. Di Nicolantonio proslijedio/la je Tweet
Principal methods for measuring chromatin accessibility:
#DNAse-seq#ATAC-seq#MNase-seq#NOMe-seq Figure from our Review: Chromatin accessibility and the regulatory epigenome http://rdcu.be/bh1yE by@WJGreenleaf et al.pic.twitter.com/Y2ZUUSY0vx
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
F. Di Nicolantonio proslijedio/la je Tweet
Lack of detectable neoantigen depletion signals in the untreated cancer genome (Van den Eynden et al.) https://go.nature.com/2rsGseV pic.twitter.com/AVMMsI2NGN
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
F. Di Nicolantonio proslijedio/la je Tweet
What's new and exciting in the
#cancerresearch field? Read the EACR’s latest Top 10 Cancer Research Publications on#TheCancerResearcher magazine: http://zpr.io/ts2yg pic.twitter.com/PXbERODSNe
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
F. Di Nicolantonio proslijedio/la je Tweet
New work from Reis-Filho and
@PedramRazavi1 in @NatureMedicine reporting a comprehensive#cfDNA analysis revealing#clonalhematopoiesis as major source of somatic mutations in plasma. @sloan_kettering#breastcancer#lungcancerhttps://www.nature.com/articles/s41591-019-0652-7 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Congrats
@nlbigas for this@NatureGenet paper on the#mutational footprints of#cancer therapies.#Oxaliplatin for 21 wks causes 20 coding-affecting mutations in#colorectal tumors, while aging induces only 1 mutation https://rdcu.be/bW3D1Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
F. Di Nicolantonio proslijedio/la je Tweet
Our first paper just published @NatureCancer! Nabel &co report trispecific antibodies that engage multiple targets & induce enhanced tumor-cell killing. Links here: Free Access Paper: https://www.nature.com/articles/s43018-019-0004-z … N&Vs@Nature: https://www.nature.com/articles/d41586-019-03495-3 … Enjoy! Stay tuned for more!!pic.twitter.com/NL7ItGt15a
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Congrats
@FilippoPietran4 and INT team for their trial just published in@CCR_AACR Capecitabine and#temozolomide versus FOLFIRI in#RAS mutated, MGMT methylated metastatic#colorectal cancer. Decreased toxicity seen with capecitabine and temozolomide.https://clincancerres.aacrjournals.org/content/early/2019/11/16/1078-0432.CCR-19-3024 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
F. Di Nicolantonio proslijedio/la je Tweet
This academic trial in colorectal cancer investigated an old drug, temozolomide, for which big pharmas do not longer invest. It was hard to run it!
@CCR_AACRhttps://clincancerres.aacrjournals.org/content/early/2019/11/16/1078-0432.CCR-19-3024 …Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Thanks to
@CD_AACR for the highlight of our recent@sciencemagazine paper on Adaptive Mutability and Resistance to#Targeted Therapies in#coloncancerhttps://cancerdiscovery.aacrjournals.org/content/early/2019/11/14/2159-8290.CD-RW2019-173 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
F. Di Nicolantonio proslijedio/la je Tweet
Our DNA repair/QC machinery is permissive, for good reasons, as put forth by
@SerenaNikZainal & Benjamin Hall@Cambridge_Uni https://science.sciencemag.org/content/366/6467/802 … explaining the high N of passenger mutations (1000 to 10,000 per genome) in normal cells@sciencemagazine#cancer@ScienceVisualspic.twitter.com/R5aul5qY9g
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
F. Di Nicolantonio proslijedio/la je Tweet
Preclinical evidence indicating that a DNA-PK inhibitor increases the activity of PARP inhibitors through increased genomic instability (via inhibition of NHEJ): https://www.nature.com/articles/s41467-019-12836-9?utm_source=twitter&utm_medium=social&utm_content=organic&utm_campaign=NRRJ_2_SJB_nrclinonc_editorial_socialposts …. Also see: https://www.nature.com/articles/s41571-018-0114-z?utm_source=twitter&utm_medium=social&utm_content=organic&utm_campaign=NRRJ_2_SJB_nrclinonc_editorial_socialposts …
#caxtxHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.